The Future of Real-World Evidence: From Supplementary Data to Evidence as a Service

Real-world evidence has evolved from a supplementary resource into an increasingly important part of regulatory, clinical, and commercial decision-making. As health data infrastructure matures and advances in AI, analytics, and interoperability make more data usable, the opportunity is shifting from simply generating evidence to making it faster, more connected, and continuously available.

This evolution is giving rise to Evidence as a Service (EaaS): a model that moves beyond one-off studies toward continuous, on-demand evidence generation. In this fireside chat, our experts will explore what is driving this shift, how emerging technologies could reshape the RWE landscape, and what life sciences organizations should consider as evidence generation becomes a more persistent and scalable capability.

Key Learnings

Attendees will gain insights into:

• The evolution of RWE and why the industry is moving beyond traditional, one-time retrospective studies.
• Evidence as a Service and what continuous, on-demand evidence generation could mean for life sciences organizations.
• The role of AI and unstructured data in expanding how clinical information can be identified, analyzed, and used.
• The shift from data to clinical intelligence, including how connected data sources can support faster, more actionable insights.
• What comes next for RWE and how organizations can prepare for a future where evidence generation becomes an ongoing capability rather than an individual project.